Use of cotinine in treating psychiatric disorders
First Claim
1. A method of treating a patient suffering from obsessive-compulsive disorder, said method comprising,providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of obsessive-compulsive disorder.
6 Assignments
0 Petitions
Accused Products
Abstract
Methods are provided for treating schizophrenia, Tourette'"'"'s Syndrome, obsessive-compulsive disorder, substance abuse or substance addiction including drug or alcohol addiction, manic-depression syndrome, anexoria or bulimia comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof, which amount is effective to reduce or alleviate at least one of the symptoms of schizophrenia, Tourette'"'"'s Syndrome, obsessive-compulsive disorder, substance abuse or substance addiction including drug or alcohol addiction, manic-depression syndrome, anexoria or bulimia in a human or other mammal.
-
Citations
14 Claims
-
1. A method of treating a patient suffering from obsessive-compulsive disorder, said method comprising,
providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of obsessive-compulsive disorder.
-
3. A method of treating a patient suffering from Tourette'"'"'s Syndrome, said method comprising,
providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of Tourette'"'"'s Syndrome.
-
5. A method of treating a patient suffering schizophrenia, said method comprising,
providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of schizophrenia.
-
7. A method of treating a patient suffering from substance abuse or substance addiction, said method comprising,
providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of substance abuse or substance addiction.
-
11. A method of treating a patient suffering from manic-depression syndrome, said method comprising,
providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of manic-depression syndrome.
-
13. A method of treating a patient suffering from anorexia or bulimia, said method comprising,
providing for such a patient a pharmaceutical agent comprising cotinine or a pharmaceutically acceptable salt thereof in a dosage between about 0.5 mg/kg to 100 mg/kg body weight per day for alleviating, in a human in need of such treatment, at least one of the symptoms of anorexia or bulimia.
Specification